Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001493152-26-038327
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$619.93K | $35.44K | -$661.71K | -$1.41M |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end
